Firas El Chaer

Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T-cell Therapy for Lymphoma: Predictive Biomarkers and Clinical Outcomes.

A. Rapoport, S. Bentzen, C. Shanholtz, 2020, Neuro-oncology.

Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience.

E. Shpall, R. Chemaly, E. Ariza-Heredia, 2016, Antiviral research.

Rapid relapse of large B‐cell lymphoma after CD19 directed CAR‐T‐cell therapy due to CD‐19 antigen loss

Seung Tae Lee, A. Rapoport, C. Shanholtz, 2019, American journal of hematology.

Relapsed Philadelphia Chromosome-Positive Pre-B-ALL after CD19-Directed CAR-T Cell Therapy Successfully Treated with Combination of Blinatumomab and Ponatinib

E. Sausville, Seung Tae Lee, M. Baer, 2019, Acta Haematologica.

Mycobacterium avium complex-associated cholecystitis in AIDS patient: a case description and review of literature

V. Hemmige, L. Woc-colburn, H. E. El Sahly, 2016, International journal of STD & AIDS.

High-risk acute promyelocytic leukemia with unusual T/myeloid immunophenotype successfully treated with ATRA and arsenic trioxide-based regimen

L. Tang, M. Baer, Z. Singh, 2018, Journal of Hematopathology.